Source: Eur Respir J 2003 Oct 01;22(4):709-711



Rating:

Share or cite this content

Citations should be made in the following way:
Korniszewski L., Kurzyna M., Stolarski B., Torbicki A., Smerdel A., Ploski R.. Fatal primary pulmonary hypertension in a 30-yr-old female with APECED syndrome. Eur Respir J 2003 Oct 01;22(4):709-711

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary hypertension in antisynthetase syndrome: prevalence, aetiology and survival Source: Eur Respir J 2013; 42: 1271-1282 Year: 2013 Bronchiectasis and autoimmune disease Source: Eur Respir Mon 2011; 52: 192-210 Year: 2011 Autoimmune polyglandular syndrome and pulmonary arterial hypertension Source: Eur Respir J 2006; 27: 657 Year: 2006 Portopulmonary hypertension: a further clue to pathogenesis? Source: Annual Congress 2005 - Challenges in the biological understanding of pulmonary arterial hypertension Year: 2005 Pulmonary hypertension in collagen vascular disease Source: Eur Respir J 2002; 19: 571-576 Year: 2002 Genetic predisposition and pathogenetic mechanisms of interstitial lung diseases of unknown origin Source: Eur Respir J 2001; 18: 17S-29S Year: 2001 Women: lung and autoimmune disease Source: ISSN=1025-448x, ISBN=1-904097-28-6, page=190 Year: 2003 Idiopathic nonspecific interstitial pneumonia: an interstitial lung disease associated with autoimmune disorders? Source: Eur Respir J 2011; 38: 384-391 Year: 2011 Autoimmunity and pulmonary hypertension: a perspective Source: Eur Respir J 2005; 26: 1110-1118 Year: 2005 Auto-immunity in idiopathic and scleroderma-related PAH Source: Research Seminar 2008 - The Pulmonary Circulation: Scleroderma-Related Pulmonary Arterial Hypertension Year: 2008 Charactaristics and prognosis of autoimmune antibody-positive patients of idiopathic pulmonary arterial hypertension Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond Year: 2021 Broncho-obstructive syndrome in patients with granulomatous pulmonary diseases. Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage Year: 2019 TBX4 syndrome: a systemic disease highlighted by pulmonary arterial hypertension in its most severe form Source: Eur Respir J, 55 (5) 2000585; 10.1183/13993003.00585-2020 Year: 2020 1 year evolution of pulmonary hypertension in patients with connective tissue diseases and secondary antiphospholipid syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 280s Year: 2004 Undifferentiated systemic rheumatic diseases and overlap syndromes: when can we diagnose interstitial pneumonia with autoimmune features (IPAF)? Source: International Congress 2018 – Respiratory medicine meets rheumatology Year: 2018 The pulmonary disorders associated with autoimmune pancreatitis Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases Year: 2008 A major genetic determinant of autoimmune diseases is associated with the presence of autoantibodies in hypersensitivity pneumonitis Source: Eur Respir J, 56 (2) 1901380; 10.1183/13993003.01380-2019 Year: 2020 Primary pulmonary hypertension in families with hereditary haemorrhagic telangiectasia Source: Eur Respir J 2004; 23: 373-377 Year: 2004 Pulmonary arterial hypertension in a patient with stage II sarcoidosis and Hashitoxicosis Source: Eur Respir Rev 2009; 18: 125-128 Year: 2009 Lymphoid interstitial pneumonia should be suspected in children with autoimmune disease and immune deficiency Source: Virtual Congress 2020 – From the bronchoscope to the clinic: paediatric bronchology at a glance Year: 2020